TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Sanofi AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,000,065
|
898,816
|
754,331 |
| Financial expenses |
3,038
|
105
|
936 |
| Earnings before taxes |
45,446
|
25,556
|
36,677 |
| EBITDA |
46,082
|
25,973
|
37,563 |
| Total assets |
541,095
|
521,909
|
371,874 |
| Current assets |
537,012
|
516,850
|
366,990 |
| Current liabilities |
427,243
|
420,154
|
261,309 |
| Equity capital |
100,922
|
88,382
|
97,261 |
| - share capital |
1,708
|
1,767
|
1,757 |
| Employees (average) |
131
|
122
|
144 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.7%
|
16.9%
|
26.2% |
| Turnover per employee |
7,634
|
7,367
|
5,238 |
| Profit as a percentage of turnover |
4.5%
|
2.8%
|
4.9% |
| Return on assets (ROA) |
9.0%
|
4.9%
|
10.1% |
| Current ratio |
125.7%
|
123.0%
|
140.4% |
| Return on equity (ROE) |
45.0%
|
28.9%
|
37.7% |
| Change turnover |
130,979
|
140,600
|
-9,227 |
| Change turnover % |
15%
|
19%
|
-1% |
| Chg. No. of employees |
9
|
-22
|
-10 |
| Chg. No. of employees % |
7%
|
-15%
|
-6% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.